Avenue Therapeutics
(NASDAQ:ATXI)
$0.2952
0.0029[0.99%]
At close: Aug 16
$0.296
0.0008[0.27%]
After Hours: 4:11PM EDT
Day High/Low0.29 - 0.3
52 Week High/Low0.2 - 1.25
Open / Close0.3 / 0.3
Float / Outstanding- / 22.1M
Vol / Avg.- / 262.5K
Mkt Cap6.5M
P/E-
50d Avg. Price0.27
Div / Yield-
Payout Ratio-
EPS-0.05
Total Float12M

Avenue Therapeutics (NASDAQ:ATXI), Quotes and News Summary

Avenue Therapeutics (NASDAQ: ATXI)

Day High/Low0.29 - 0.3
52 Week High/Low0.2 - 1.25
Open / Close0.3 / 0.3
Float / Outstanding- / 22.1M
Vol / Avg.- / 262.5K
Mkt Cap6.5M
P/E-
50d Avg. Price0.27
Div / Yield-
Payout Ratio-
EPS-0.05
Total Float12M
Sector: Health Care.Industry: Pharmaceuticals
Avenue Therapeutics Inc is a specialty pharmaceutical company that develops and markets pharmaceutical products for the acute care setting. It focuses on developing its product candidate, an intravenous (IV) formulation of tramadol HCI (IV Tramadol), for post-operative acute pain.

Earnings

see more
Q3 2022Est.ActualSurprise
EPS
(EXPECTED)2022-11-14
REV
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-30
REV

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Avenue Therapeutics Questions & Answers

Q
How do I buy Avenue Therapeutics (ATXI) stock?
A

You can purchase shares of Avenue Therapeutics (NASDAQ: ATXI) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Avenue Therapeutics's (ATXI) competitors?
Q
What is the target price for Avenue Therapeutics (ATXI) stock?
A

The latest price target for Avenue Therapeutics (NASDAQ: ATXI) was reported by HC Wainwright & Co. on Tuesday, May 12, 2020. The analyst firm set a price target for 13.00 expecting ATXI to rise to within 12 months (a possible 4303.79% upside). 0 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Avenue Therapeutics (ATXI)?
A

The stock price for Avenue Therapeutics (NASDAQ: ATXI) is $0.2952 last updated August 16, 2022, 8:00 PM UTC.

Q
Does Avenue Therapeutics (ATXI) pay a dividend?
A

There are no upcoming dividends for Avenue Therapeutics.

Q
When is Avenue Therapeutics (NASDAQ:ATXI) reporting earnings?
A

Avenue Therapeutics’s Q3 earnings are confirmed for Monday, November 14, 2022.

Q
Is Avenue Therapeutics (ATXI) going to split?
A

There is no upcoming split for Avenue Therapeutics.

Q
What sector and industry does Avenue Therapeutics (ATXI) operate in?
A

Avenue Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.